Use these links to rapidly review the document
TABLE OF CONTENTS
TABLE OF CONTENTS

Table of Contents

Filed Pursuant to Rule 424(b)(5)
Registration No.: 333-143451

The information in this preliminary prospectus supplement is not complete and may be changed. This preliminary prospectus supplement and the accompanying prospectus are neither offers to sell nor solicitations of offers to buy these securities in any jurisdiction where the offer or sale thereof is not permitted.

Subject to Completion
Preliminary Prospectus Supplement dated May 3, 2010

PROSPECTUS SUPPLEMENT
(To Prospectus dated March 3, 2009)

25,000,000 Shares

KKR Financial Holdings LLC

Common Shares



         We are offering 25,000,000 common shares of KKR Financial Holdings LLC.

         Our common shares are traded on the New York Stock Exchange, or NYSE, under the symbol "KFN." The closing price of our common shares on May 3, 2010 was $9.19 per share.

         Ownership of our shares by any person is generally limited to 9.8% in value or in number of shares, whichever is more restrictive. In addition, our operating agreement contains other limitations on the ownership and transfer of our shares. However, pursuant to our operating agreement, our board of directors may, under certain circumstances, terminate these limitations on ownership and transfer of our shares or grant exemptions to certain persons. For additional information on the ownership and transfer restrictions on our shares, see "Description of Shares—Certain Provisions of the Operating Agreement—Restrictions on Ownership and Transfer" in the accompanying prospectus.

         We are externally managed and advised by KKR Financial Advisors LLC (the "Manager"). The Manager is an indirect subsidiary of Kohlberg Kravis Roberts & Co. L.P. ("KKR"). KKR holds a controlling interest in the parent of KKR Capital Markets LLC, an underwriter in this offering. See "Underwriting" beginning on page S-20 of this prospectus supplement.



          Investing in our common shares involves risks. See "Risk Factors" beginning on page S-5 of this prospectus supplement.



 
  Per Share   Total  

Public offering price

 
$
 
$
 

Underwriting discount

  $     $    

Proceeds, before expenses, to us

  $     $    

         Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of this prospectus supplement or the accompanying prospectus. Any representation to the contrary is a criminal offense.

         The underwriters may also purchase up to an additional 3,750,000 common shares at the public offering price, less the underwriting discounts and commissions, to cover over-allotments, if any, within 30 days of the date of this prospectus supplement. If the underwriters exercise this option in full, the total underwriting discounts and commissions will be $            , and our total proceeds, before expenses, will be $            .

         The underwriters are offering the common shares as set forth under "Underwriting." Delivery of the common shares will be made on or about May             , 2010.

Joint Book-Runners

BofA Merrill Lynch

 

Citi

 

Deutsche Bank
Securities

 

KKR

 

Morgan Stanley


Co-Managers

FBR Capital
Markets

 

JMP Securities

 

Keefe, Bruyette &
Woods

 

Sandler O'Neill +
Partners, L.P.

The date of this prospectus supplement is May             , 2010.


Table of Contents


TABLE OF CONTENTS

 
  Page

Prospectus Supplement

   

About This Prospectus Supplement

 
S-ii

Where You Can Find More Information

  S-ii

Summary

  S-1

Risk Factors

  S-5

Use of Proceeds

  S-9

Capitalization

  S-10

Price Range of Common Shares and Distributions

  S-11

Distribution Policy

  S-12

Ownership Limitations

  S-13

Additional Material U.S. Federal Income Tax Considerations

  S-14

Certain Erisa Considerations

  S-18

Underwriting

  S-20

Conflicts of Interest

  S-26

Legal Matters

  S-26

Experts

  S-26

Incorporation by Reference

  S-27

Prospectus

   

KKR Financial Holdings LLC

  4

Risk Factors

  8

Cautionary Note Regarding Forward-Looking Statements

  8

Use of Proceeds

  9

Ratios of Earnings to Fixed Charges

  10

Material U.S. Federal Income Tax Considerations

  11

Description of Shares

  31

Description of Depositary Shares

  43

Description of Warrants

  48

Description of Subscription Rights

  50

Description of Debt Securities and Guarantees

  51

Description of Share Purchase Contracts and Share Purchase Units

  72

Plan of Distribution

  73

Legal Matters

  74

Experts

  74

Where You Can Find More Information

  74

Incorporation by Reference

  75



        Unless otherwise expressly stated or the context otherwise requires, the terms "we," "our company," "us" and "our" and similar terms refer, as of dates and for periods on and after May 4, 2007, to KKR Financial Holdings LLC and its subsidiaries and, as of dates and for periods prior to May 4, 2007, to our predecessor, KKR Financial Corp., and its subsidiaries; "Manager" means KKR Financial Advisors LLC; "KKR" means Kohlberg Kravis Roberts & Co. L.P. and its affiliated companies (excluding portfolio companies that are minority or majority owned or managed by funds associated with KKR); "management agreement" means the amended and restated management agreement (as heretofore amended) between KKR Financial Holdings LLC and the Manager; "operating agreement" means the amended and restated operating agreement of KKR Financial Holdings LLC (as heretofore amended); "common shares" and "preferred shares" mean common shares and preferred shares, respectively, representing limited liability company interests in KKR Financial Holdings LLC; references to "our shares" (and similar references) mean common shares and preferred shares of KKR Financial Holdings LLC; and references to "$" and "dollars" mean United States dollars.

S-i


Table of Contents


ABOUT THIS PROSPECTUS SUPPLEMENT

        This document consists of two parts. The first part is this prospectus supplement, which describes the specific terms of this offering. The second part is the accompanying prospectus, which describes more general information, some of which may not apply to this offering. You should read both this prospectus supplement and the accompanying prospectus, together with additional information described under the headings "Where You Can Find More Information" and "Incorporation by Reference" below.

        If the description of the offering varies between this prospectus supplement and the accompanying prospectus, you should rely on the information in this prospectus supplement.

        Any statement made in this prospectus supplement or in a document incorporated or deemed to be incorporated by reference in this prospectus supplement will be deemed to be modified or superseded for purposes of this prospectus supplement to the extent that a statement contained in this prospectus supplement or in any other subsequently filed document that is also incorporated or deemed to be incorporated by reference in this prospectus supplement modifies or supersedes that statement. Any statement so modified or superseded will not be deemed, except as so modified or superseded, to constitute a part of this prospectus supplement. See "Incorporation by Reference."

         We have not authorized anyone to provide any information or to make any representations other than those contained or incorporated by reference in this prospectus supplement, the accompanying prospectus or in any free writing prospectuses we have prepared. We take no responsibility for, and can provide no assurance as to the reliability of, any other information that others may give you. This prospectus supplement, the accompanying prospectus and any such free writing prospectus is an offer to sell only the common shares offered hereby, but only under circumstances and in jurisdictions where it is lawful to do so. You should not assume that the information in this prospectus supplement, the accompanying prospectus, any related free writing prospectus or any document incorporated or deemed incorporated herein by reference is accurate as of any date other than the date of this prospectus supplement. Also, you should not assume that there has been no change in the affairs of our company since the date of this prospectus supplement. Our business, financial condition, results of operations and prospects may have changed since that date.


WHERE YOU CAN FIND MORE INFORMATION

        We have filed with the Securities and Exchange Commission (the "SEC") a registration statement on Form S-3 under the Securities Act of 1933, as amended (the "Securities Act"), of which this prospectus supplement is a part, with respect to the securities to be sold pursuant to this prospectus supplement. This prospectus supplement does not contain all of the information set forth in the registration statement and exhibits to the registration statement. For further information with respect to us and the securities to be sold pursuant to this prospectus supplement, reference is made to the registration statement, including the exhibits to the registration statement. Statements contained in the prospectus, this prospectus supplement and in the documents incorporated and deemed to be incorporated by reference herein or in any free writing prospectus as to the contents of any contract or other document do not purport to be complete and, where that contract or document is an exhibit to the registration statement or an exhibit to a document incorporated or deemed to be incorporated by reference in the registration statement, each statement is qualified in all respects by reference to the exhibit to which the reference relates. Copies of the registration statement, including the exhibits to the registration statement, and other documents we file with the SEC may be examined without charge at the public reference room of the SEC, 100 F Street, N.E., Washington, D.C. 20549. Information about the operation of the public reference room may be obtained by calling the SEC at 1-800-SEC-0300. Copies of the registration statement, including the exhibits, and the other documents we file with the SEC can be obtained from the public reference room of the SEC upon payment of prescribed fees. Our SEC filings, including our registration statement, are also available to you for free on the SEC's website at http://www.sec.gov. You may also inspect information that we file with the NYSE at the offices of the NYSE at 20 Broad Street, New York, New York 10005. We are subject to the information and reporting requirements of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and file periodic reports, proxy statements and other information with the SEC.

S-ii


Table of Contents


SUMMARY

         This summary highlights selected information contained elsewhere or incorporated or deemed incorporated by reference in this prospectus supplement and the accompanying prospectus and does not contain all of the information you should consider when making your investment decision. We urge you to carefully read all of this prospectus supplement, the accompanying prospectus and the documents incorporated or deemed incorporated by reference, including our consolidated financial statements and accompanying notes, to gain a fuller understanding of our business and the terms of our shares, as well as some of the other considerations that may be important to you, before making your investment decision. You should pay special attention to the "Risk Factors" section of this prospectus supplement and the documents incorporated or deemed incorporated by reference to determine whether an investment in our shares is appropriate for you.


KKR Financial Holdings LLC

        We are a specialty finance company with expertise in a range of asset classes. Our core business strategy is to leverage the proprietary resources of our Manager with the objective of generating both current income and capital appreciation. We primarily invest in financial assets including below investment grade corporate debt, including senior secured and unsecured loans, mezzanine loans, high yield corporate bonds, distressed and stressed debt securities, marketable equity securities and credit default swaps. Additionally, we have made or may make investments in other asset classes including natural resources and real estate. The corporate loans we invest in are primarily referred to as syndicated bank loans, or leveraged loans, and are purchased via assignment or participation in either the primary or secondary market. The majority of our corporate debt investments are held in collateralized loan obligation ("CLO") transactions that are structured as on-balance sheet securitizations and are used as long term financing for these investments. The senior secured notes issued by the CLO transactions are primarily owned by unaffiliated third party investors and we own the majority of the subordinated notes in the CLO transactions. We execute our core business strategy through majority-owned subsidiaries, including CLOs.

        We are externally managed and advised by KKR Financial Advisors LLC, our Manager and an affiliate of KKR, pursuant to the management agreement between us and our Manager. Our Manager was formed in July 2004. All of our executive officers are either employees or members of our Manager or one or more of its affiliates. The executive offices of our Manager are located at 555 California Street, 50th Floor, San Francisco, California 94104 and the telephone number of our Manager's executive offices is (415) 315-3620.

Recent Developments

        On May 3, 2010, we, together with certain of our subsidiaries (collectively, the "Borrowers"), entered into a Credit Agreement (the "2010 Credit Agreement") with Citibank, N.A., Bank of America, N.A., Deutsche Bank AG New York Branch and Morgan Stanley Bank, N.A. The 2010 Credit Agreement provides for a four-year $210 million asset-based revolving credit facility. The facility is subject, among other things, to the terms of a borrowing base derived from the value of eligible specified financial assets. The borrowing base is subject to certain caps and concentration limits customary for financings of this type. The Borrowers may obtain additional commitments under the facility so long as the aggregate amount of commitments at any time does not exceed $600 million.

        The Borrowers have the right to prepay loans under the facility in whole or in part at any time. All amounts borrowed under the 2010 Credit Agreement must be repaid on or before May 3, 2014. Initial borrowings under the 2010 Credit Agreement are subject to, among other things, the substantially concurrent repayment by the Borrowers of all amounts due and owing under our existing credit facility and such facility's effective termination.

S-1


Table of Contents

        Loans under the 2010 Credit Agreement bear interest, at the Borrowers' option, at a rate equal to the London interbank offered rate ("LIBOR") plus 3.25% per annum or an alternate base rate. Ongoing extensions of credit under the 2010 Credit Agreement are subject to customary conditions, including sufficient availability under the borrowing base. The 2010 Credit Agreement contains customary negative covenants applicable to the Borrowers and their subsidiaries, including negative covenants that restrict the ability of such entities to, among other things, (i) incur additional indebtedness, (ii) allow certain liens to attach to such entities' assets, and (iii) make distributions to our shareholders in excess of 65% of our annual taxable income or make certain other restricted payments. In addition, the 2010 Credit Agreement also includes financial covenants, including requirements that we:

    maintain adjusted consolidated tangible net worth (as defined in the 2010 Credit Agreement) of at least $700 million plus an amount equal to 25% of the net proceeds received from the issuance and sale of any of our or our subsidiaries equity interests (as defined in the 2010 Credit Agreement); and

    not exceed a leverage ratio (as defined in the 2010 Credit Agreement) of 2.00 to 1.00 computed on a basis that generally excludes the debt of variable interest entities that we consolidate under GAAP.

        The 2010 Credit Agreement also includes other covenants, representations, warranties, indemnities and events of default, that are customary for facilities of this type, including events of default relating to a change of control.

S-2


Table of Contents


The Offering

Issuer

  KKR Financial Holdings LLC

Common Shares Offered by Us

 

25,000,000

Overallotment Option

 

3,750,000

Common Shares to Be Outstanding After this Offering

 

183,359,757 (or 187,109,757 shares if the underwriting overallotment is exercised in full)

Restrictions on Ownership

 

Our operating agreement contains restrictions on the number of our shares that a person may own that are intended to assist us in maintaining the qualification of any REIT subsidiary of ours as a REIT under the Internal Revenue Code of 1986, as amended, or the "Code." Among other things, the operating agreement provides that, subject to exceptions, no person may beneficially or constructively own shares in excess of 9.8% in value or number, whichever is more restrictive, of our outstanding shares, excluding shares not treated as outstanding for U.S. federal income tax purposes. In addition, the operating agreement, subject to exceptions, prohibits any person from beneficially owning our shares to the extent that such ownership of shares would result in any REIT subsidiary of ours being "closely-held" under Section 856(h) of the Code (without regard to whether the ownership interest is held during the last half of a taxable year) or would otherwise cause any REIT subsidiary of ours to fail to qualify as a REIT. For more information about these restrictions, see "Description of Shares—Certain Provisions of the Operating Agreement—Restrictions on Ownership and Transfer" in the accompanying prospectus.

Trading

 

Our common shares are listed on the NYSE under the symbol "KFN."

Material U.S. Federal Income Tax Considerations

 

You should read carefully the section "Additional Material U.S. Federal Income Tax Considerations" in this prospectus supplement and the section "Material U.S. Federal Income Tax Considerations" in the prospectus, as well as the tax risk factors that are included and incorporated or deemed incorporated by reference herein, for certain U.S. federal income tax considerations relevant to our common shares.

Use of Proceeds

 

We estimate that the net proceeds from the sale of the 25,000,000 common shares in this offering, after deducting the underwriters' discount and estimated offering expenses, will be approximately $219,411,250 (or approximately $252,322,938 if the underwriters' overallotment option is exercised in full). We expect to use the net proceeds from this offering to acquire assets in accordance with our core business strategy and for general corporate purposes.

S-3


Table of Contents

Risk Factors

 

You should read carefully the "Risk Factors" beginning on page S-5 of this prospectus supplement, as well as the risk factors that are described in the documents incorporated or deemed incorporated by reference in this prospectus supplement, for certain considerations relevant to an investment in our common shares.

Conflicts of Interest

 

An affiliate of KKR Capital Markets LLC owns a controlling interest in our Manager. As a result, KKR Capital Markets LLC may be deemed to have a "conflict of interest" under the applicable provisions of Rule 2720 of the Financial Industry Regulatory Authority. For more information, see "Conflicts of Interest."

        The number of common shares to be outstanding immediately after this offering is based on 158,359,757 common shares outstanding as of April 22, 2010 and excludes:

    an aggregate of approximately 21,139,705 common shares issuable upon conversion of our outstanding 7.50% Convertible Senior Notes due 2017 at an applicable conversion price of $8.16 per common share, which includes an adjustment to the conversion price as a result of the Company's distribution paid to its common shareholders through the date hereof;

    an aggregate of approximately 5,825,064 common shares issuable upon conversion of our outstanding 7.00% Convertible Senior Notes due 2012 at an applicable conversion price of $31.00 per common share;

    1,932,279 common shares issuable upon the exercise of options outstanding as of March 31, 2010, having a weighted-average exercise price of $20.00 per share;

    1,942,200 common shares authorized, but not yet issued under our 2007 Incentive Share Plan; and

    279,624 common shares reserved, but not yet issued under our Non-Employee Directors' Deferred Compensation and Share Award Plan.

S-4


Table of Contents


RISK FACTORS

         Investing in our common shares involves risks. You should carefully review the following risk factors and the risks discussed under the caption "Risk Factors" in our Annual Report on Form 10-K filed with the SEC on March 1, 2010, which is incorporated by reference in this prospectus supplement, in our Quarterly Report on Form 10-Q filed with the SEC on April 29, 2010, or any similar caption in the documents that we subsequently file with the SEC that are deemed to be incorporated by reference in this prospectus supplement and the accompanying prospectus, and in any free writing prospectus that you may be provided in connection with the offering of common shares pursuant to this prospectus supplement and the accompanying prospectus. You should also carefully review the other risks and uncertainties discussed in this prospectus supplement and the accompanying prospectus, the documents incorporated and deemed to be incorporated by reference in this prospectus supplement and in any free writing prospectus. The risks and uncertainties discussed below and in the documents referred to above, as well as other matters discussed in this prospectus supplement and in those documents, could materially and adversely affect our business, financial condition, liquidity and results of operations and the market price of our common shares. Moreover, the risks and uncertainties discussed below and in the foregoing documents are not the only risks and uncertainties that we face, and our business, financial condition, liquidity and results of operations and the market price of our common shares could be materially adversely affected by other matters that are not known to us or that we currently do not consider to be material risks to our business.

Risks Related to Ownership of Our Shares and the Offering

The market price and trading volume of our common shares may be volatile.

        The market price of our common shares may be highly volatile and could be subject to wide fluctuations. In addition, the trading volume in our common shares may fluctuate and cause significant price variations to occur. We cannot assure you that the market price of our common shares will not fluctuate or decline significantly in the future. Some of the factors that could negatively affect our share price or result in fluctuations in the price or trading volume of our common shares include those set forth in this "Risk Factors" section, under "Cautionary Note Regarding Forward-Looking Statements" in the accompanying prospectus and in the information incorporated and deemed to be incorporated by reference herein, as well as:

    actual or anticipated variations in our quarterly operating results or business prospects;

    changes in our earnings estimates or publication of research reports about us or the real estate industry;

    an inability to meet or exceed securities analysts' estimates or expectations;

    increases in market interest rates;

    hedging or arbitrage trading activity in our common shares;

    capital commitments;

    changes in market valuations of similar companies;

    adverse market reaction to any increased indebtedness we incur in the future;

    additions or departures of management personnel;

    actions by institutional shareholders;

    speculation in the press or investment community;

    changes in our distribution policy;

    general market and economic conditions; and

S-5


Table of Contents

    future sales of our common shares or securities convertible into, or exchangeable or exercisable for, our common shares.

        Many of the factors listed above are beyond our control. These factors may cause the market price of our common shares to decline, regardless of our financial condition, results of operations, business or prospects. It is impossible to assure you that the market prices of our common shares will not fall in the future.

Future sales of a significant number of our common shares in the public markets, or the perception that such sales could occur, could depress the market price of our common shares.

        Sales of a substantial number of our common shares or other equity-related securities in the public markets, or the perception that such sales could occur, could depress the market price of our common shares and impair our ability to raise capital through the sale of additional equity securities. The issuance of these shares may also have the effect of reducing our net income per share to unexpected levels and could reduce the market price of our common shares unless revenue growth or cost savings sufficient to offset the effect of such issuance can be achieved. We cannot predict the effect that future sales of our common shares or other equity-related securities would have on the market price of our common shares or the trading price of our shares.

Certain provisions of our operating agreement will make it difficult for third parties to acquire control of us and could deprive holders of our common shares of the opportunity to obtain a takeover premium for their shares.

        Our operating agreement contains a number of provisions that could make it more difficult for a third party to acquire, or may discourage a third party from acquiring, control of us. These provisions include, among others:

    restrictions on our ability to enter into certain transactions with major holders of our shares or their affiliates or associates modeled on certain limitations contained in Section 203 of the General Corporation Law of the State of Delaware;

    allowing only our board of directors to fill newly created directorships;

    requiring that directors may be removed only for cause (as defined in the operating agreement) and then only by a vote of at least two-thirds of the votes entitled to be cast in the election of directors;

    requiring advance notice for holders of our shares to nominate candidates for election to our board of directors or to propose matters to be considered by holders of our shares at a meeting of holders of our shares;

    our ability to issue additional securities, including, but not limited to, preferred shares, without approval by holders of our common shares;

    a prohibition on any person beneficially or constructively owning shares in excess of 9.8% in value or number of our outstanding shares, excluding shares not treated as outstanding for U.S. federal income tax purposes, whichever is more restrictive;

    the ability of our board of directors to amend the operating agreement without approval of the holders of our common shares except under certain specified circumstances; and

    limitations on the ability of holders of our common shares to call special meetings of holders of our common shares or to act by written consent.

S-6


Table of Contents

        These provisions, as well as other provisions in the operating agreement, may delay, defer or prevent a transaction or a change in control that might otherwise result in holders of our common shares obtaining a takeover premium for their shares.

        Certain provisions of the management agreement also could make it more difficult for third parties to acquire control of us by various means, including limitations on our right to terminate the management agreement and a requirement that, under certain circumstances, we make a substantial payment to the Manager in the event of a termination.

We may issue additional debt and equity securities that are senior to our common shares as to distributions and upon our dissolution, which could materially adversely affect the market price of our common shares.

        In the future, we may attempt to increase our capital resources by entering into additional debt or debt-like financings that are secured by all or some of our assets, or issuing debt or equity securities, which could include issuances of secured liquidity notes, medium-term notes, senior notes, subordinated notes or preferred and common shares. In the event of our dissolution, liabilities of our creditors, including our lenders and holders of our debt securities, would be satisfied from our available assets in priority to distributions to holders of our common or preferred shares. Any preferred shares may have a preference over our common shares with respect to distributions made at the discretion of our board of directors, which could further limit our ability to make distributions to holders of our common shares. Because our decision to incur debt and issue shares in any future offerings will depend on the terms of our operating agreements, market conditions and other factors beyond our control, we cannot predict or estimate the amount, timing or nature of our future offerings or our future debt and equity financings. Further, market conditions could require us to accept less favorable terms for the issuance of our securities in the future, including, but not limited to, issuing common shares at a discount to market value. Accordingly, holders of our shares and of any securities we may issue whose value is linked to the value of our shares will bear the risk of our future offerings reducing the value of their shares or any such other securities and diluting their interest in us. In addition, we can change our leverage strategy and investment policies from time to time without approval of holders of any of our shares, which could adversely affect the market price of our shares.

Our board of directors has broad authority to change many of the terms of our common shares without the approval of holders of our common shares.

        Our operating agreement gives our board of directors broad authority to effect amendments to the provisions of our operating agreement that could change many of the terms of our common shares without the consent of holders of our common shares. As a result, our board of directors may, without the approval of holders of our common shares, make changes to many of the terms of our common shares that are adverse to the holders of our common shares.

Our board of directors has full authority and discretion over distributions on our common shares and it may decide to reduce or eliminate distributions at any time, which may adversely affect the market price for our common shares and any other securities we may issue.

        Our board of directors has full authority and sole discretion to determine whether or not a distribution will be declared and paid, and the amount and timing of any distribution that may be paid, to holders of our shares and (unless otherwise provided by our board of directors if and when it establishes the terms of any new class or series of our shares) any other class or series of shares we may issue in the future. Our board of directors may, in its sole discretion, determine to reduce or eliminate distributions on our common shares and (unless otherwise so provided by our board of directors) any other class or series of shares we may issue in the future, which may have a material adverse effect on the market price of our shares, any such other shares and any other securities we may issue. In addition, in computing U.S. federal income tax liability for a taxable year, each holder of our

S-7


Table of Contents


shares will be required to take into account its allocable share of items of our income, gain, loss, deduction and credit for our taxable year ending within or with such holder's taxable year, regardless of whether such holder has received any distributions. As a result, it is possible that a holder's U.S. federal income tax liability with respect to its allocable share of these items in a particular taxable year could exceed the cash distributions received by such holder.

        In addition, as discussed under the caption "Risk Factors—Risks Related to our Organization and Structure—The terms of our indebtedness may restrict our ability to make future distributions and impose limitations on our current and future operations" in our Annual Report on Form 10-K for the fiscal year ended December 31, 2009, our credit facility includes covenants that restricts our ability to make distributions on, and to redeem or repurchase, our shares, including a prohibition on distributions on, and redemptions and repurchases of, our shares if an event of default, or certain events that with notice or passage of time or both would constitute an event of default, under the credit facility occur and a requirement that we maintain a specified minimum level of consolidated tangible net worth. Our 2010 Credit Agreement, initial borrowings of which are subject to, among other things, the substantially concurrent repayment by the Borrowers of all amounts due and owing under our existing credit facility, also includes similar covenants and restrictions on our ability to make distributions on, and to redeem or repurchase, our common shares. In addition, the 2010 Credit Agreement contains a covenant which limits our ability to make distributions to our shareholders in an amount in excess of 65% of our annual taxable income.

Our failure to pay quarterly distributions to holders of our common shares could cause the market price of our common shares to decline significantly.

        On November 29, 2009, our board of directors declared a cash distribution of $0.05 per common share that was paid on December 21, 2009 to common shareholders of record as of December 7, 2009. On February 4, 2010, our board of directors declared a cash distribution of $0.07 per common share. The distribution was paid on March 4, 2010 to common shareholders of record as of the close of business on February 18, 2010. On April 29, 2010, our board of directors declared a cash distribution of $0.10 per common share. The distribution will be paid on May 28, 2010 to common shareholders of record as of the close of business on May 14, 2010.

        Our ability to pay quarterly distributions will be subject to, among other things, general business conditions, our financial results, the impact of paying distributions on our credit ratings, and legal and contractual restrictions on the payment of distributions, including restrictions imposed by our existing credit facility as well as the terms of our 2010 Credit Agreement. Any reduction or discontinuation of quarterly distributions could cause the market price of our common shares to decline significantly. Our payment of distributions to holders of our common shares may in certain future quarters also result in upward adjustments to the conversion rate of our 7.50% Convertible Senior Notes due 2017 and our 7.00% Convertible Senior Notes due 2012. Moreover, in the event our payment of quarterly distributions is reduced or discontinued, our failure or inability to resume paying distributions could result in a persistently low market valuation of our common shares.

S-8


Table of Contents


USE OF PROCEEDS

        We estimate that the net proceeds from the sale of the 25,000,000 common shares in this offering, after deducting the underwriters' discount and estimated offering expenses, will be approximately $219,411,250 (or approximately $252,322,938 if the underwriters' overallotment option is exercised in full). We expect to use the net proceeds from this offering to acquire assets in accordance with our core business strategy and for general corporate purposes.

S-9


Table of Contents


CAPITALIZATION

        The following table sets forth our consolidated capitalization as of March 31, 2010:

    on an actual basis; and

    as adjusted to reflect the offering of our common shares (based on an assumed offering price of $9.19 per share, the closing price on the NYSE on May 3, 2010) and the application of the net proceeds as described under "Use of Proceeds," assuming that the underwriters do not exercise their option to purchase additional common shares.

        This table should be read in conjunction with the information contained herein under the heading "Use of Proceeds," and under the heading "Management's Discussion and Analysis of and Financial Condition and Results of Operations" and in our consolidated financial statements and notes thereto, included in our Annual Report on Form 10-K for the year ended December 31, 2009 and in our Quarterly Report on Form 10-Q for the three months ended March 31, 2010, and incorporated by reference in this prospectus supplement. In addition, you should read this table together with the information appearing above under "Summary—Recent Developments."

 
  As of March 31, 2010  
 
  Actual   As adjusted  
 
  (Unaudited)
(Dollars in thousands)

 
 

Cash and cash equivalents(1)

  $ 240,529   $    
           

Borrowings:

             
 

Collateralized loan obligation senior secured notes

  $ 5,631,866   $ 5,631,866  
 

Collateralized loan obligation junior secured notes issued to affiliates

    380,343     380,343  
 

Senior secured credit facility

    150,000     150,000  
 

Convertible senior notes

    343,303     343,303  
 

Junior subordinated notes

    283,517     283,517  
           
   

Total borrowings

    6,789,029     6,789,029  
           

Shareholders' equity:

             

Preferred shares, no par value, 50,000,000 shares authorized and none issued and outstanding at March 31, 2010

         

Common shares, no par value, 500,000,000 shares authorized, and 158,359,757 shares issued and outstanding at March 31, 2010, actual; 183,359,757 shares issued and outstanding at March 31, 2010, as adjusted

         

Paid-in-capital

    2,576,501        

Accumulated other comprehensive income

    170,413     170,413  

Accumulated deficit

    (1,431,294 )   (1,431,294 )
           
   

Total shareholders' equity

    1,315,620        
           
     

Total capitalization

  $ 8,104,649   $    
           

(1)
Assumes that the net proceeds from the offering will be held initially as cash and cash equivalents.

S-10


Table of Contents


PRICE RANGE OF COMMON SHARES AND DISTRIBUTIONS

        Our common shares have been listed on the NYSE under the symbol "KFN" since the time of the conversion transaction on May 4, 2007. The common stock of KKR Financial Corp., our predecessor, was traded on the NYSE from June 24, 2005 until the effectiveness of the conversion transaction. As of April 22, 2010, we had 158,359,757 common shares outstanding. The following table sets forth, for the periods indicated, the high and low sales prices per share of the common shares as reported on the NYSE.

 
  Share Prices  
 
  High   Low  

Year Ended December 31, 2010

             

Second Quarter (through May 3, 2010)

  $ 9.49   $ 8.20  

First Quarter ended March 31, 2010

    8.50     5.55  

Year Ended December 31, 2009

             

Fourth Quarter ended December 31, 2009

  $ 5.95   $ 4.10  

Third Quarter ended September 30, 2009

    5.25     0.75  

Second Quarter ended June 30, 2009

    2.35     0.78  

First Quarter ended March 31, 2009

    2.64     0.40  

Year Ended December 31, 2008

             

Fourth Quarter ended December 31, 2008

  $ 6.99   $ 0.57  

Third Quarter ended September 30, 2008

    11.34     5.15  

Second Quarter ended June 30, 2008

    13.72     10.28  

First Quarter ended March 31, 2008

    16.78     10.12  

        The following table sets forth the cash distributions declared per common share for fiscal years 2008, 2009 and 2010. We did not declare any cash distributions in the fourth quarter of fiscal year 2008 or during the first three quarters of fiscal year 2009.

Record Date   Payment Date   Cash Distribution Declared Per
Common Share
 

February 15, 2008

  February 29, 2008   $ 0.50  

May 15, 2008

  May 30, 2008   $ 0.40  

August 15, 2008

  August 29, 2008   $ 0.40  

December 7, 2009

  December 21, 2009   $ 0.05  

February 18, 2010

  March 4, 2010   $ 0.07  

May 14, 2010

  May 28, 2010   $ 0.10  

S-11


Table of Contents


DISTRIBUTION POLICY

        In light of the economic conditions that prevailed through the later part of 2008 and into the third quarter of 2009, we suspended making distributions to the holders of our common shares during such period. On November 29, 2009, our board of directors declared a cash distribution of $0.05 per common share that was paid on December 21, 2009 to common shareholders of record as of December 7, 2009. On February 4, 2010, our board of directors declared a cash distribution of $0.07 per common share. The distribution was paid on March 4, 2010 to common shareholders of record as of the close of business on February 18, 2010. On April 29, 2010, our board of directors declared a cash distribution of $0.10 per common share. The distribution will be paid on May 28, 2010 to common shareholders of record as of the close of business on May 14, 2010. However, we cannot assure you that similar, or any, distribution will be made to holders of our common shares during future periods.

        Our board of directors has full authority and sole discretion to determine whether or not a distribution will be declared and paid, and the amount and timing of any distribution that may be paid, to holders of our common shares and (unless otherwise provided by our board of directors if and when it establishes the terms of any new class or series of our shares) any other class or series of shares we may issue in the future. Our board of directors may, in its sole discretion, determine to reduce or eliminate distributions on our common shares and (unless otherwise so provided by our board of directors) any other class or series of shares we may issue in the future, which may have a material adverse effect on the market price of our common shares and any such other shares. As a result, distributions to holders of our shares will depend on a number of factors, including:

    our financial condition;

    general business conditions;

    our results of operations;

    our available capital and leverage;

    our debt service requirements;

    cash distributions to us from our subsidiaries;

    our operating expenses;

    our taxable income;

    our liquidity requirements;

    our distribution yield relative to our peers;

    restrictions under Delaware law;

    any contractual, legal and regulatory restrictions on the payment of distributions by us to holders of our shares or by our subsidiaries to us; and

    other factors our board of directors in its discretion deems relevant.

        Our existing credit facility as well as our 2010 Credit Agreement, initial borrowings of which are subject to, among other things, the substantially concurrent repayment by the Borrowers of all amounts due and owing under our existing credit facility, include covenants that could restrict our ability to make distributions on our common shares and any other class or series of shares we may issue in the future, including a prohibition on distributions on our shares if an event of default, or certain events that with notice or passage of time or both would constitute an event of default, under the applicable credit agreement occur and a requirement that we maintain a specified minimum level of consolidated tangible net worth.

S-12


Table of Contents


OWNERSHIP LIMITATIONS

        Our operating agreement contains restrictions on the number of our shares that a person may own that are intended to assist us in maintaining the qualification of any REIT subsidiary of ours as a REIT under the Code. Among other things, the operating agreement provides that, subject to exceptions, no person may beneficially or constructively own shares in excess of 9.8% in value or number, whichever is more restrictive, of our outstanding shares, excluding shares not treated as outstanding for U.S. federal income tax purposes. In addition, the operating agreement, subject to exceptions, prohibits any person from beneficially owning our shares to the extent that such ownership of shares would result in any REIT subsidiary of ours being "closely held" under Section 856(h) of the Code (without regard to whether the ownership interest is held during the last half of a taxable year) or would otherwise cause any REIT subsidiary of ours to fail to qualify as a REIT. The operating agreement generally provides that any attempted transfer which, if effective, would result in a violation of the foregoing restrictions will cause the number of shares causing the violation (rounded up to the nearest whole share) to be automatically transferred to a charitable trust. The operating agreement further generally provides that, if the transfer of shares to a charitable trust would not be effective for any reason to prevent a violation of the foregoing restrictions, then, to the fullest extent permitted by law, the transfer of that number of shares that would otherwise cause that violation shall be void ab initio. For further information about these and other related provisions of our operating agreement, see "Description of Shares—Certain Provisions of the Operating Agreement—Restrictions on Ownership and Transfer" in the accompanying prospectus.

S-13


Table of Contents


ADDITIONAL MATERIAL U.S. FEDERAL INCOME TAX CONSIDERATIONS

        The following discussion supplements the discussion under the heading "Material U.S. Federal Income Tax Considerations" in the accompanying prospectus. The following is a summary of certain material U.S. federal income tax considerations relating to the acquisition, ownership and disposition of our common shares.

        This discussion does not purport to be a complete analysis of all the potential tax considerations relating thereto. The information in this section is based on the Code, current, temporary and proposed Treasury Regulations, the legislative history of the Code, current administrative interpretations and practices of the Internal Revenue Service, or the IRS, including its practices and policies as endorsed in private letter rulings, which are not binding on the IRS (except with respect to the taxpayer that received the ruling), and existing court decisions. Future legislation, regulations, administrative interpretations and court decisions could change current law or adversely affect existing interpretations of current law. Any change could apply retroactively. It is possible that the IRS could challenge the statements in this discussion, which do not bind the IRS or the courts, and that a court could agree with the IRS.

        This summary deals only with common shares held as "capital assets" (within the meaning of Section 1221 of the Code) and does not address tax considerations applicable to an investor's particular circumstances or to investors that may be subject to special tax rules, including, without limitation, financial institutions (including banks), insurance companies, dealers in securities or currencies, persons subject to the mark-to-market rules of the Code, persons that will hold our common shares as a position in a hedging transaction, "integrated transaction," "straddle" or "conversion transaction" for tax purposes, persons who are, or who hold common shares through, entities treated as partnerships for U.S. federal income tax purposes, U.S. Holders (as defined below) that have a "functional currency" other than the U.S. dollar, persons subject to the alternative minimum tax provisions of the Code and, except as expressly indicated below, tax-exempt organizations and non-U.S. Holders (as defined below).

        In addition, if a partnership (including for this purpose any entity treated as a partnership for U.S. federal income tax purposes) is a holder of our common shares, the tax treatment of a partner in the partnership will generally depend upon the status of the partner and upon the activities of the partnership. Holders that are partnerships, and partners in such partnerships, should consult their tax advisors about the U.S. federal income tax consequences of purchasing, holding and disposing of our common shares.

         Investors considering the purchase of our common shares should consult their tax advisors with respect to the application of the U.S. federal income tax laws to their particular situations as well as any tax consequences arising under the laws of any state, local or foreign taxing jurisdiction or under any applicable tax treaty.

        As used herein, the term "U.S. Holder" means any beneficial owner of our common shares, that is, for U.S. federal income tax purposes, (i) a citizen or resident, as defined in Section 7701(b) of the Code, of the United States, (ii) a corporation (or other entity treated as a corporation for U.S. federal income tax purposes) created or organized in or under the laws of the United States, any state thereof or the District of Columbia, (iii) an estate the income of which is subject to U.S. federal income taxation regardless of its source, or (iv) in general, a trust subject to the primary supervision of a U.S. court and the control of one or more U.S. persons or a trust that was both treated as a domestic trust on August 19, 1996 and in existence on August 20, 1996 and has made a valid election to be treated as a U.S. person. As used herein, the term "non-U.S. Holder" means a beneficial owner of our common shares (other than a partnership or an entity or arrangement treated as a partnership for U.S. federal income tax purposes) that is not a U.S. Holder. The term "holder" includes both a U.S. Holder and a non-U.S. Holder.

S-14


Table of Contents

U.S. Federal Income Tax Consequences of the Ownership and Disposition of Our Common Shares

        The following is a summary of certain additional U.S. federal income tax considerations related to the ownership and disposition of our common shares.

        Disposition of Our Common Shares.     The IRS has ruled that a partner who acquires interests in a partnership in separate transactions must combine those interests and maintain a single adjusted tax basis for all those interests. Upon a sale or other disposition of less than all of those interests, a portion of that adjusted tax basis must be allocated to the interests sold using an "equitable apportionment" method, which generally means that the adjusted tax basis allocated to the interests sold equals an amount that bears the same relation to the partner's adjusted tax basis in all of the partner's interests in the partnership as the value of the interests sold bears to the value of all of the partner's interests in the partnership. Notwithstanding the requirement set forth in the IRS ruling, if a holder sells fewer than all of its common shares, we generally will report to the holder the amount of gain treated under Section 751(a) of the Code as ordinary income based on the assumption that the first common shares purchased were also the first common shares sold, which is sometimes referred to as a "first-in, first-out" method. See "Material U.S. Federal Income Tax Considerations—U.S. Federal Income Tax Consequences of the Ownership and Disposition of Our Shares—Disposition of Interest" in the accompanying prospectus. We generally use the same assumption to make basis adjustments to our assets required as a result of our election under Section 754 of the Code. See "Material U.S. Federal Income Tax Considerations—U.S. Federal Income Tax Consequences of the Ownership and Disposition of Our Shares—Tax Elections" in the accompanying prospectus. This assumption is for administrative convenience only and is not consistent with the IRS's ruling that a partner must maintain a single adjusted tax basis in its partnership interest. A holder should inform us if the holder uses a method other than "first-in, first-out" to determine its basis for any common shares disposed.

        In addition, Treasury Regulations under Section 1223 of the Code allow a selling holder of our common shares who can identify common shares transferred with an ascertainable holding period to elect to use the actual holding period of the common shares transferred. Thus, although according to the IRS ruling discussed above, a holder of our common shares will be unable to select high or low basis common shares to sell as would be the case with corporate stock, such holder may, according to these Treasury Regulations, designate specific common shares sold for purposes of determining the holding period of common shares transferred. A holder electing to use the actual holding period of common shares transferred must consistently use that identification method for all subsequent sales or exchanges of common shares. A holder considering the purchase of additional common shares or a sale of common shares purchased in separate transactions is urged to consult the holder's own tax advisor as to the possible consequences of this IRS ruling and application of the Treasury Regulations.

        Cancellation of Indebtedness Income.     We have recognized and may recognize in the future cancellation of indebtedness income upon the retirement of our debt at a discount. Although there is no direct authority addressing the issue, we believe that our cancellation of indebtedness income will constitute other income derived from our business of investing in stocks and securities and thus, will be qualifying income for purposes of the qualifying income exception described in "Material U.S. Federal Income Tax Considerations—U.S. Federal Income Tax Consequences of the Ownership and Disposition of Our Shares—Classification of KKR Financial Holdings LLC" in the accompanying prospectus.

        Allocation of Profits and Losses.     The monthly convention that we apply pursuant to which our taxable income and losses is determined annually and prorated on a monthly basis, see "Material U.S. Federal Income Tax Considerations—U.S. Federal Income Tax Consequences of the Ownership and Disposition of Our Shares—Allocation of Profits and Losses" in the accompanying prospectus, is in accordance with recently proposed Treasury Regulations, on which existing publicly traded partnerships may currently rely.

S-15


Table of Contents

        "Anti-Stapling" Rules.     Currently, we have several subsidiaries that could be subject to a significant tax liability under the "anti-stapling" rules, including one subsidiary taxed as a REIT (KFH II), three foreign corporate subsidiaries (KKR TRS Holdings Ltd., KKR Financial Holdings, Ltd. and KFH III Holdings, Ltd.), and four domestic corporate subsidiaries (KFN PEI VII, LLC, KFH PE Holdings I LLC, KFH PE Holdings II LLC and KKR Financial Holdings, Inc.). See "Material U.S. Federal Income Tax Considerations—U.S. Federal Income Tax Consequences of the Ownership and Disposition of Our Shares—"Anti-Stapling" Rules" in the accompanying prospectus.

        Withholding Taxes.     For payments made after December 31, 2012, a U.S. withholding tax at a 30% rate will apply to distributions that constitute "withholdable payments" and proceeds of sale in respect of our common shares received by U.S. Holders who own their stock through foreign accounts or foreign intermediaries or received by certain non-U.S. Holders, in each case if certain disclosure requirements related to U.S. accounts or ownership are not satisfied. If payment of withholding taxes is required, non-U.S. Holders that are otherwise eligible for an exemption from, or reduction of, U.S. withholding taxes with respect to such distributions and proceeds will be required to seek a refund from the IRS to obtain the benefit or such exemption or reduction. In addition, for payments made on or after September 14, 2010, U.S. withholding tax will apply to "dividend equivalent payments" made pursuant to certain securities lending or notional principal contract transactions allocable to non-U.S. Holders. We will not pay any additional amounts to holders in respect of any amounts withheld.

        Medicare Tax.     For taxable years beginning after December 31, 2012, certain U.S. Holders who are individuals, estates or trusts and whose income exceeds certain thresholds will be required to pay a 3.8% Medicare tax. The Medicare tax will apply to, among other things, interest, dividends and other income derived from certain trades or business and net gains from the sale or other disposition of certain interests in a partnership, subject to certain exceptions. Our income will generally be the type of income that is subject to the Medicare tax and any gain from the disposition of our common shares will be the type of gain that is subject to the tax.

        Tax Consequences of Investments in Natural Resources.     As referenced above, we may make certain investments in natural resources. Income and gains derived from certain activities related to minerals and natural resources are treated as "qualifying income" for purposes of the "qualifying income exception" applicable to publicly traded partnerships. We expect that our investments in natural resources would generally generate "qualifying income" for purposes of this exception. See "Material U.S. Federal Income Tax Considerations—U.S. Federal Income Tax Consequences of the Ownership and Disposition of Our Shares—Classification of KKR Financial Holdings LLC" in the accompanying prospectus. It is likely that the income from such investments would be treated as effectively connected with the conduct of a U.S. trade or business with respect to non-U.S. Holders of our common shares. See "Material U.S. Federal Income Tax Considerations—U.S. Federal Income Tax Consequences of the Ownership and Disposition of Our Shares—Non-U.S. Holders" in the accompanying prospectus for a discussion of the treatment of U.S. trade or business income. Moreover, under the Foreign Investment in Real Property Tax Act ("FIRPTA"), a non-U.S. Holder may be subject to FIRPTA withholding on the disposition of our common shares if (1) the non-U.S. Holder owned (directly or constructively applying certain attribution rules) more than 5% of our common shares at any time during the five-year period ending on the date of such disposition (a "5% non-U.S. Holder") and (2) the fair market value of our investments in U.S. real property interests represented more than 10% of the total fair market value of our assets at any time during the applicable testing period. Currently, we believe we do not hold any U.S. real property interests, but certain of our future investments in real estate and natural resources may be treated as U.S. real property interests. No assurance can be provided that our future investments in U.S. real property interests will not cause us to exceed the 10% threshold described above, in which event any 5% non-U.S. Holder would be subject to 10% withholding tax on the gross proceeds from the disposition of our common shares. Income or loss from our investments in natural resources is expected to be treated as income or loss from passive activities, and to the extent

S-16


Table of Contents


that it is so treated, will be subject to the rules described in "Material U.S. Federal Income Tax Considerations—U.S. Federal Income Tax Consequences of the Ownership and Disposition of Our Shares—Limitation on Deductibility of Certain of Our Losses" in the accompanying prospectus. In addition, investments in natural resources may produce unrelated business taxable income for tax-exempt holders of our common shares. To the extent that such income is unrelated business taxable income, it will be subject to the rules described in "Material U.S. Federal Income Tax Considerations—U.S. Federal Income Tax Consequences of the Ownership and Disposition of Our Shares—Unrelated Business Taxable Income" in the accompanying prospectus.

        Tax Consequences of Investments in Real Estate.     We do not currently have any investments in real estate. As referenced above, we may make investments in real estate in the future. We intend generally to make any future investments in real estate through one or more REIT subsidiaries. See "Material U.S. Federal Income Tax Considerations—Material U.S. Federal Income Tax Considerations Relating to Investments in REITs" for a discussion of the tax consequences of our ownership of REIT subsidiaries.

        New Legislation or Administrative or Judicial Action.     The rules dealing with U.S. federal income taxation are constantly under review by persons involved in the legislative process, the IRS and the Treasury, frequently resulting in revised interpretations of established concepts, statutory changes, revisions to regulations and other modifications and interpretations. No assurance can be given as to whether, or in what form, any proposals affecting us or our shareholders will be enacted. The IRS pays close attention to the proper application of tax laws to partnerships. The present U.S. federal income tax treatment of an investment in our common shares may be modified by administrative, legislative or judicial interpretation at any time, and any such action may affect investments and commitments previously made. For example, the U.S. federal income tax rules relating to publicly traded partnerships are currently under review by Congress, and certain legislative proposals have been made that would affect the tax treatment of publicly traded partnerships. While we believe that the current legislative proposals would not adversely affect the manner in which we will be taxed, no assurance can be given as to whether, or in what form, such proposals will ultimately be enacted, or whether they will have an effect on us. We and holders of our common shares could be adversely affected by any such change in, or any new, tax law, regulation or interpretation. Our organizational documents and agreements permit the board of directors to modify the operating agreement from time to time, without the consent of the holders of common shares, in order to address certain changes in U.S. federal income tax regulations, legislation or interpretation. In some circumstances, such revisions could have a material adverse effect on some or all of the holders of our common shares.

S-17


Table of Contents


CERTAIN ERISA CONSIDERATIONS

        Each fiduciary of a pension, profit-sharing or other employee benefit plan subject to the Employee Retirement Income Security Act of 1974, as amended ("ERISA") (a "Plan"), should consider the fiduciary standards of ERISA in the context of the Plan's particular circumstances before authorizing an investment in our common shares. Accordingly, among other factors, the fiduciary should consider whether the investment would satisfy the prudence and diversification requirements of ERISA and would be consistent with its fiduciary responsibilities, and the documents and instruments governing the Plan.

        In addition, we and certain of our subsidiaries and affiliates may be each considered a party in interest within the meaning of ERISA, or a disqualified person within the meaning of the Code, with respect to many Plans, as well as other arrangements subject to Section 4975 of the Code, including individual retirement accounts and Keogh plans (such arrangements also referred to herein as "Plans"). Prohibited transactions within the meaning of ERISA or the Code would likely arise, for example, if our common shares are acquired by or with the assets of a Plan with respect to which we or any of our subsidiaries or affiliates is a party in interest, unless the transaction qualifies for an exemption from the prohibited transaction rules of ERISA and the Code. A violation of these prohibited transaction rules could result in an excise tax or other liabilities under ERISA and/or Section 4975 of the Code for such persons, unless exemptive relief is available under an applicable statutory or administrative exemption.

        Exemptive relief from the prohibited transaction rules under ERISA and the Code may be available for direct or indirect prohibited transactions resulting from the purchase, holding or disposition of our common shares. Those exemptions include Prohibited Transaction Class Exemption ("PTCE") 96-23 (for certain transactions determined by in-house asset managers), PTCE 95-60 (for certain transactions involving insurance company general accounts), PTCE 91-38 (for certain transactions involving bank collective investment funds), PTCE 90-1 (for certain transactions involving insurance company separate accounts), and PTCE 84-14 (for certain transactions determined by independent qualified asset managers). In addition, the exemption under Section 408(b)(17) of ERISA and Section 4975(d)(20) of the Code provides exemptive relief for certain arm's-length transactions with a person (other than a fiduciary or an affiliate of a fiduciary that has or exercises discretionary authority or control or renders investment advice with respect to the assets involved in the transaction) that is a party in interest solely by reason of providing services to Plans or being an affiliate of such a service provider (the "Service Provider Exemption"). However, there can be no assurance that any of these class exemptions, the statutory exemption or any other exemption will be available with respect to any particular transaction involving our common shares.

        Because we or our affiliates may be considered a party in interest or disqualified person with respect to many Plans, our shares may not be purchased, held, converted or disposed of by any Plan, any entity whose underlying assets include plan assets by reason of any Plan's investment in the entity (a"Plan Asset Entity") or any person investing plan assets of any Plan, unless such purchase, holding, conversion or disposition is eligible for exemptive relief, including relief available under PTCE 96-23, 95-60, 91-38, 90-1, or 84-14 or the Service Provider Exemption, or such purchase, holding, conversion or disposition is otherwise not prohibited. Any purchaser, including any fiduciary purchasing on behalf of a Plan, transferee or holder of our common shares will be deemed to have represented, in its corporate and its fiduciary capacity, by its purchase and holding of our common shares that either (a) it is not a Plan or a Plan Asset Entity and is not purchasing such common shares on behalf of or with plan assets of any Plan or with any assets of a governmental, church or foreign plan that is subject to any federal, state, local or foreign law that is substantially similar to the provisions of Section 406 of ERISA or Section 4975 of the Code or (b) (i) its purchase, holding, conversion and disposition of our common shares will not constitute or result in a non-exempt prohibited transaction or will satisfy the conditions required for exemptive relief under a prohibited transaction exemption and (ii) such purchase, holding, conversion and disposition are not otherwise prohibited by ERISA or Section 4975

S-18


Table of Contents


of the Code (or in the case of a governmental, church or foreign plan, any substantially similar federal, state, local or foreign law).

        Under ERISA, assets of a Plan may include assets held in the general account of an insurance company which has issued an insurance policy to such plan or assets of an entity in which the Plan has invested. Accordingly, insurance company general accounts that include assets of a Plan must ensure that one of the foregoing exemptions is available. Due to the complexity of these rules and the penalties that may be imposed upon persons involved in non-exempt prohibited transactions, it is particularly important that fiduciaries or other persons considering purchasing our shares on behalf of or with "plan assets" of any Plan consult with their counsel regarding the availability of exemptive relief under PTCE 96-23, 95-60, 91-38, 90-1 or 84-14, the Service Provider Exemption or another exemption.

        Purchasers of our common shares have exclusive responsibility for ensuring that their purchase, holding, conversion and disposition of our common shares do not violate the prohibited transaction rules of ERISA or the Code or any substantially similar regulations applicable to governmental or church plans, as described above.

S-19


Table of Contents


UNDERWRITING

        We are offering the common shares described in this prospectus supplement through a number of underwriters. Citigroup Global Markets Inc., Deutsche Bank Securities Inc., KKR Capital Markets LLC, Merrill Lynch, Pierce, Fenner & Smith Incorporated and Morgan Stanley & Co. Incorporated are the representatives of the underwriters named below. Subject to the terms and conditions of the underwriting agreement, we have agreed to sell to the underwriters, and each underwriter has severally agreed to purchase, at the public offering price less the underwriting discount set forth on the cover page of this prospectus supplement, the number of common shares listed next to its name in the following table:

                       Underwriter
  Number of
Common Shares
 
    $    
       
Citigroup Global Markets Inc.         
Deutsche Bank Securities Inc.         
KKR Capital Markets LLC        
Merrill Lynch, Pierce, Fenner & Smith
                        Incorporated
       
Morgan Stanley & Co. Incorporated        
FBR Capital Markets & Co.         
JMP Securities LLC        
Keefe, Bruyette & Woods, Inc.         
Sandler O'Neill + Partners, L.P.         
       
  Total   $    
       

        The underwriters are committed to purchase all the common shares offered by us if they purchase any shares. The underwriting agreement also provides that if an underwriter defaults, the purchase commitments of non-defaulting underwriters may also be increased or the offering may be terminated.

        The underwriters propose to offer the common shares directly to the public at the public offering price set forth on the cover page of this prospectus supplement and to certain dealers at that price less a concession not in excess of $            per share. After the public offering of the shares, the offering price and other selling terms may be changed by the underwriters. The underwriters have an option to buy up to                        additional common shares from us to cover sales of shares by the underwriters which exceed the number of shares specified in the table above. The underwriters have 30 days from the date of this prospectus supplement to exercise this over-allotment option. If any shares are purchased with this over-allotment option, the underwriters will purchase shares in approximately the same proportion as shown in the table above. If any additional common shares are purchased, the underwriters will offer the additional shares on the same terms as those on which the shares are being offered.

        At our request, the underwriters have agreed to reserve up to 1% of the common shares for sale in this offering to our executive officers at the offering price.

        The underwriting fee is equal to the public offering price per common share less the amount paid by the underwriters to us per common share. The underwriting fee is $            per share. The following table shows the per share and total underwriting discounts to be paid to the underwriters, assuming both no exercise and full exercise of the underwriters' option to purchase additional shares.

 
  Per Common Share   No Exercise   Full Exercise  

Public offering price

  $     $     $    

Underwriting discount

  $     $     $    

Proceeds, before expenses, to us

  $     $     $    

S-20


Table of Contents